fda bpc-157 safety risks compounding Big news for the peptide space. The Pharmacy Advisory Committee recently voted eight to six in favor of allowing compounding pharmacies to produce BPC 157. Here is what you need FDA Issues Warning: Compounding Certain

Meanwhile, the FDA's own career scientists are recommending against giving compounding pharmacies the green light to produce any of the seven peptides under consideration

\n\n\n\n BPC-157 Antidepressant and Anxiety Research in Animal Models \n\n\n\n Perhaps the most unexpected area of BPC-157 neurological research involves its interaction with dopaminergic and serotonergic neurotransmitter systems

Researchers discovered its powerful protective and healing effects, particularly in the gastrointestinal (GI) tract

ACE2 is abundantly present in the brush border of enterocytes, especially in the small intestinal mucosa

After she is admitted to the hospital, her condition improves

Role of calcitonin gene-related peptide in cerebral vasospasm, and as a therapeutic approach to subarachnoid hemorrhage